Russia announces coronavirus deaths exceed 10,000

Russia has confirmed 674,515 cases, the third largest total in the world. (AFP)
Short Url
Updated 04 July 2020

Russia announces coronavirus deaths exceed 10,000

  • Russia has confirmed 674,515 cases, the third largest total in the world, although the daily infection rate has been falling over the last month

MOSCOW: Russia on Saturday said that it recorded more than 10,000 deaths from the coronavirus pandemic, a toll that is still far lower than in other countries with major outbreaks.
The number of deaths has now reached 10,027, the government information website said, up by 168 from Friday.
Russia has confirmed 674,515 cases, the third largest total in the world, although the daily infection rate has been falling over the last month.
The country’s death toll is much lower than in other countries with large outbreaks, raising questions over possible underreporting of deaths.
Russia has acknowledged that the death figure on the government website only includes cases where the virus was classed as the main cause of death on the death certificate.
The official statistics agency has released national death data for April alone, where the toll — of 2,712 — is more than double the government’s total of 1,152 for that month.
That is because it uses a broader definition on the basis of World Health Organization recommendations and includes cases where the victim tested positive but the virus was not classified as the main cause of death, or where there was no positive test but an autopsy ruled the virus was the main cause of death.
Moscow city health department also released data on deaths in May using this method of classification, showing 5,260 virus-related deaths that month.
By contrast, the government website still says that some 3,929 people in total have died so far from the virus just in Moscow.


US to pay over $1 bn for 100 mln doses of J&J’s potential COVID-19 vaccine

Updated 05 August 2020

US to pay over $1 bn for 100 mln doses of J&J’s potential COVID-19 vaccine

  • The latest contract equates to roughly $10 per vaccine dose produced by J&J
  • This is J&J’s first deal to supply its investigational vaccine to a country

WASHINGTON: The United States government will pay Johnson & Johnson over $1 billion for 100 million doses of its potential coronavirus vaccine, its latest such arrangement as the race to tame the pandemic intensifies, the drugmaker said on Wednesday.
It said it would deliver the vaccine to the Biomedical Advanced Research and Development Authority (BARDA) on a not-for-profit basis to be used after approval or emergency use authorization by the US Food and Drug Administration (FDA).
J&J has already received $1 billion in funding from the US government — BARDA agreed in March to provide that money for the company to build manufacturing capacity for more than 1 billion doses of the experimental vaccine.
The latest contract equates to roughly $10 per vaccine dose produced by J&J. Including the first $1 billion deal with the USgovernment, the price would be slightly higher than the $19.50 per dose that the United States is paying for the vaccine being developed by Pfizer Inc. and German biotech BioNTech SE.
The US government may also purchase an additional 200 million doses under a subsequent agreement. J&J did not disclose that deal’s value.
J&J plans to study a one- or two-dose regimen of the vaccine in parallel later this year. A single-shot regimen could allow more people to be vaccinated with the same number of doses and would sidestep issues around getting people to come back for their second dose.
This is J&J’s first deal to supply its investigational vaccine to a country. Talks are underway with the European Union, but no deal has yet been reached.
J&J’s investigational vaccine is currently being tested on healthy volunteers in the United States and Belgium in an early-stage study.
There are currently no approved vaccines for COVID-19. More than 20 are in clinical trials.